...
首页> 外文期刊>Cancer Management and Research >KIF14 and KIF23 Promote Cell Proliferation and Chemoresistance in HCC Cells, and Predict Worse Prognosis of Patients with HCC
【24h】

KIF14 and KIF23 Promote Cell Proliferation and Chemoresistance in HCC Cells, and Predict Worse Prognosis of Patients with HCC

机译:KIF14和KIF23促进HCC细胞中细胞增殖和化学抑制,并预测HCC患者的更糟预后

获取原文

摘要

Background:Hepatocellular carcinoma (HCC) is one of the most common human malignant tumors. The prognosis of HCC patients is still unsatisfying. In this study, we performed the integrated bioinformatics analysis to identify potential biomarkers and biological pathways in HCC.Methods:Gene expression profiles were obtained from the Gene Expression Omnibus database (GSE55048, GSE55758, and GSE56545) for the screening of the common differentially expressed genes (DEGs) between HCC tissues and matched non-tumor tissues. DEGs were subjected to Gene Ontology, KEGG pathway, and Reactome pathway analysis. The hub genes were identified by using protein-protein interaction (PPI) network analysis. The hub genes in HCC were further subjected to overall survival analysis of HCC patients. The hub genes were further validated by in vitro functional assays.Results:A total of 544 common differentially expressed genes were screened from three datasets. Gene Ontology, KEGG and Reactome analysis results showed that DEGs are significantly associated with the biological process of cell cycle, cell division, and DNA replication. PPI network analysis identified 20 hub genes from the DEGs. These hub genes except CENPE were all significantly up-regulated in the HCC tissues when compared to non-tumor tissues. The Kaplan-Meier survival analysis results showed that the high expression of the 20 hub genes was associated with shorter survival of the HCC patients. Further validation studies showed that knockdown of KIF14 and KIF23 both suppressed the proliferative potential, increased the caspase-3/-7 activity, up-regulated Bax expression, and promoted the invasive and migratory abilities in the HCC cells. In addition, knockdown of KIF14 and KIF23 enhanced chemosensitivity to cisplatin and sorafenib in the HCC cells. Finally, the high expression of KIF14 and KIF23 was associated with shorter progression-free survival, recurrence-free survival, and disease-specific survival of patients with HCC.Conclusion:In conclusion, the present study performed the integrated bioinformatics analysis and showed that KIF14 and KIF23 silence attenuated cell proliferation, invasion, and migration, and promoted chemosensitivity of HCC cells. KIF14 and KIF23 may serve as potential biomarkers for predicting the worse prognosis of patients with HCC.? 2020 Cheng et al.
机译:背景:肝细胞癌(HCC)是最常见的人类恶性肿瘤之一。 HCC患者的预后仍然不满意。在这项研究中,我们进行了综合生物信息学分析,以鉴定HCC的潜在生物标志物和生物途径。方法:基因表达谱从基因表达综合症(GSE55048,GSE55758和GSE56545)获得常见的差异表达基因的筛选(DEGS)HCC组织和匹配的非肿瘤组织之间。将DEG进行基因本体,KEGG途径和反应途径分析。通过使用蛋白质 - 蛋白质相互作用(PPI)网络分析来鉴定轮毂基因。 HCC中的轮毂基因进一步进行HCC患者的总存活分析。通过体外功能测定进一步验证了轮毂基因。结果:从三个数据集中筛选总共544个常见的差异表达基因。基因本体,Kegg和反应分析结果表明,Degs与细胞周期,细胞分裂和DNA复制的生物过程显着相关。 PPI网络分析确定了来自DEG的20个枢纽基因。与非肿瘤组织相比,除了CENPE之外的这些轮浦基因在HCC组织中大大上调。 Kaplan-Meier存活分析结果表明,20个枢纽基因的高表达与HCC患者的较短生存相关。进一步的验证研究表明,KIF14和KIF23的敲低均抑制增殖潜力,增加了Caspase-3 / -7活性,上调的BAX表达,并促进了HCC细胞中的侵入性和迁移能力。此外,KIF14和KIF23的敲低增强了HCC细胞中的Cisplatin和Sorafenib的化学敏感性。最后,KIF14和KIF23的高表达与HCC的无进展的存活,复发的存活率和疾病特异性存活率相关联。结论:总之,本研究表演了综合生物信息学分析并显示了KIF14和KIF23沉默减毒衰减细胞增殖,侵袭和迁移,并促进了HCC细胞的化学敏感性。 KIF14和KIF23可以作为潜在的生物标志物,用于预测HCC患者的更糟糕的预后。 2020 Cheng等人。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号